HRP20100577T1 - Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti - Google Patents

Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti Download PDF

Info

Publication number
HRP20100577T1
HRP20100577T1 HR20100577T HRP20100577T HRP20100577T1 HR P20100577 T1 HRP20100577 T1 HR P20100577T1 HR 20100577 T HR20100577 T HR 20100577T HR P20100577 T HRP20100577 T HR P20100577T HR P20100577 T1 HRP20100577 T1 HR P20100577T1
Authority
HR
Croatia
Prior art keywords
agomelatine
anxiety disorder
pharmaceutically acceptable
hydrates
generalised anxiety
Prior art date
Application number
HR20100577T
Other languages
English (en)
Croatian (hr)
Inventor
Delalleau Bruno
Fabiano Agnes
Millan Mark
Mocaer Elisabeth
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100577(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20100577T1 publication Critical patent/HRP20100577T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20100577T 2006-04-07 2010-10-21 Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti HRP20100577T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number Publication Date
HRP20100577T1 true HRP20100577T1 (hr) 2010-11-30

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100577T HRP20100577T1 (hr) 2006-04-07 2010-10-21 Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti

Country Status (43)

Country Link
US (1) US7960438B2 (sr)
EP (1) EP1842535B1 (sr)
JP (1) JP4880031B2 (sr)
KR (1) KR20070100657A (sr)
CN (1) CN101049290B (sr)
AP (1) AP2488A (sr)
AR (1) AR060349A1 (sr)
AT (1) ATE477798T1 (sr)
AU (1) AU2007201527B2 (sr)
BR (1) BRPI0701601A (sr)
CA (1) CA2584060C (sr)
CO (1) CO5840252A1 (sr)
CR (1) CR9019A (sr)
CY (1) CY1111287T1 (sr)
DE (1) DE602007008494D1 (sr)
DK (1) DK1842535T3 (sr)
EA (1) EA012608B1 (sr)
ES (1) ES2351062T3 (sr)
FR (1) FR2899472B1 (sr)
GE (1) GEP20094743B (sr)
GT (1) GT200700032A (sr)
HR (1) HRP20100577T1 (sr)
IL (1) IL182407A (sr)
JO (1) JO3440B1 (sr)
MA (1) MA28987B1 (sr)
ME (1) ME01865B (sr)
MX (1) MX2007004100A (sr)
MY (1) MY143269A (sr)
NI (1) NI200700084A (sr)
NO (1) NO20071774L (sr)
NZ (1) NZ554347A (sr)
PE (1) PE20080174A1 (sr)
PL (1) PL1842535T3 (sr)
PT (1) PT1842535E (sr)
RS (1) RS51485B (sr)
SA (1) SA07280161B1 (sr)
SG (1) SG136881A1 (sr)
SI (1) SI1842535T1 (sr)
TN (1) TNSN07118A1 (sr)
TW (1) TWI374736B (sr)
UY (1) UY30262A1 (sr)
WO (1) WO2007116136A1 (sr)
ZA (1) ZA200702865B (sr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
PH12012000132A1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
ES2645223T3 (es) 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备
CN116785225A (zh) * 2022-03-15 2023-09-22 湖南慧泽生物医药科技有限公司 阿戈美拉汀鼻部制剂
CN118021721A (zh) * 2024-01-19 2024-05-14 沈阳药科大学 一种脑靶向阿戈美拉汀鼻喷胶束的制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5737438A (en) * 1994-03-07 1998-04-07 International Business Machine Corp. Image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
EP1696959A2 (en) * 2003-12-24 2006-09-06 Sepracor, Inc. Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
WO2006096434A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
AR060349A1 (es) 2008-06-11
ME01865B (me) 2011-04-30
GEP20094743B (en) 2009-07-27
CA2584060C (fr) 2011-04-26
CA2584060A1 (fr) 2007-10-07
CY1111287T1 (el) 2015-08-05
EA200700574A3 (ru) 2007-12-28
AU2007201527A1 (en) 2007-10-25
MA28987B1 (fr) 2007-11-01
FR2899472A1 (fr) 2007-10-12
HK1108367A1 (en) 2008-05-09
WO2007116136A1 (fr) 2007-10-18
AP2007003953A0 (en) 2007-04-30
DE602007008494D1 (de) 2010-09-30
EP1842535B1 (fr) 2010-08-18
MY143269A (en) 2011-04-15
US20070238792A1 (en) 2007-10-11
TNSN07118A1 (fr) 2008-06-02
NZ554347A (en) 2008-08-29
JO3440B1 (ar) 2019-10-20
PE20080174A1 (es) 2008-03-29
IL182407A0 (en) 2008-01-20
ATE477798T1 (de) 2010-09-15
TW200808295A (en) 2008-02-16
CR9019A (es) 2008-10-28
CO5840252A1 (es) 2007-12-31
EP1842535A1 (fr) 2007-10-10
MX2007004100A (es) 2009-02-16
AP2488A (en) 2012-10-03
EA012608B1 (ru) 2009-10-30
SI1842535T1 (sl) 2010-10-29
PT1842535E (pt) 2010-09-28
SG136881A1 (en) 2007-11-29
BRPI0701601A (pt) 2007-12-11
NO20071774L (no) 2007-10-08
GT200700032A (es) 2007-10-31
IL182407A (en) 2016-02-29
EA200700574A2 (ru) 2007-10-26
UY30262A1 (es) 2007-05-31
JP4880031B2 (ja) 2012-02-22
DK1842535T3 (da) 2010-11-15
CN101049290A (zh) 2007-10-10
NI200700084A (es) 2008-04-24
AU2007201527B2 (en) 2012-08-09
US7960438B2 (en) 2011-06-14
RS51485B (sr) 2011-04-30
CN101049290B (zh) 2012-10-31
JP2009532446A (ja) 2009-09-10
ZA200702865B (en) 2008-07-30
KR20070100657A (ko) 2007-10-11
SA07280161B1 (ar) 2010-10-23
FR2899472B1 (fr) 2008-09-12
PL1842535T3 (pl) 2011-01-31
ES2351062T3 (es) 2011-01-31
TWI374736B (en) 2012-10-21

Similar Documents

Publication Publication Date Title
HRP20100577T1 (hr) Uporaba agomelatina za dobivanje lijeka s ciljem liječenja općeg poremećaja anksioznosti
EA201590166A1 (ru) Комбинированная терапия для лечения рассеянного склероза
MY196599A (en) Pharmaceutical compositons comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
BR112014009851A2 (pt) moduladores de receptor de nmda e usos dos mesmos
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
RU2011137131A (ru) Производные 1-аминоалкилциклогексана для лечения тиннитуса, связанного с потерей слуха или незначительной потерей слуха
BR112014006763A2 (pt) n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1
BR0210261A (pt) Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes
MX2021014774A (es) Formulaciones de liberacion modificada y usos de las mismas.
CL2023002665A1 (es) Formas de dosificación farmacéuticas que comprenden (4s)–24–cloro–4–etil–73–fluoro–35–metoxi– 32,5–dioxo–14–(trifluorometil)–32h–6–aza–3(4,1)–piridina–1(1)–[1,2,3]triazola–2 (1,2),7(1)–dibencenaheptafano–74–carboxamida
HRP20110370T1 (hr) Uporaba agomelatina za dobivanje lijeka u cilju liječenja smith-magenisovog sindroma
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
AR062112A1 (es) Derivados ciclicos como moduladores de la actividad del receptor de quimiocina
RU2009131745A (ru) Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера
AR041891A1 (es) Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza
AR056063A1 (es) Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento de trastornos del sueno en el paciente deprimido
HRP20120344T1 (hr) N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije
RU2010107177A (ru) Новые комбинации нерамексана для лечения нейродегенеративных расстройств
SE0401655D0 (sv) New compounds
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
HRP20110083T1 (hr) Uporaba agomelatina u proizvodnji lijeka za liječenje bipolarnih poremećaja
SI2533774T1 (en) APPLICATION OF AGOMELATINES FOR PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF A VITAL COMPULSIVE DISEASE (OKM)
MX2022012693A (es) Composicion que comprende metilfolato.
RU2013114246A (ru) Комбинация hdac ингибиторов с лекарственными средствами против тромбоцитопении